Dejka M. Araujo

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-1223-6542

发表论文 179 篇 · 总被引 4914 次 · h-index 34

代表论文

• Phase 1a study results for IMA203CD8, a PRAME-directed T-cell receptor (TCR) T-cell therapy, in ovarian cancer. (2026 · Journal of Clinical Oncology · 被引 2)
• 590 A first-in-human, phase 1 trial of IMA203 PRAME-directed TCR T-cell therapy with PRAME-encoding mRNA-4203 in previously treated, unresectable or metastatic cutaneous melanoma or synovial sarcoma (2025 · Regular and Young Investigator Award Abstracts · 被引 2)
• Phase 1 study results with PRAME-directed T-cell receptor (TCR) T-cell therapies in synovial sarcoma. (2026 · Journal of Clinical Oncology · 被引 1)
• Supplementary Table S1 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)
• Supplemental Figure S3 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)
• Supplemental Figure S1 from Drug Screening of Sarcoma Cells: Finding Shared Sensitivities (2026)